Wound dressing
Latest Bristol-Myers Squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
The FIGURE is an elevational plan view of a wound dressing showing our new design.
Claims
We claim the ornamental design for a wound dressing, as shown and described.
Referenced Cited
Patent History
Patent number: D484602
Type: Grant
Filed: Aug 22, 2002
Date of Patent: Dec 30, 2003
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Bryan Griffiths (Chester), Helen Shaw (Widnes), Simon Adams (Holywell), Stephen Bishop (Deeside)
Primary Examiner: Stella Reid
Attorney, Agent or Law Firm: John M. Kilcoyne
Application Number: 29/166,184
Type: Grant
Filed: Aug 22, 2002
Date of Patent: Dec 30, 2003
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Bryan Griffiths (Chester), Helen Shaw (Widnes), Simon Adams (Holywell), Stephen Bishop (Deeside)
Primary Examiner: Stella Reid
Attorney, Agent or Law Firm: John M. Kilcoyne
Application Number: 29/166,184
Classifications
Current U.S. Class:
Bandage For Protection Or Treatment (53) (D24/189)
International Classification: 2404;
International Classification: 2404;
